1. Alexander GJ, Eddieston AL (1986) Does maternal antibody to core antigen prevent recognition of transplacental transmission of hepatitis-B-virus infection2. Lancet 1: 296–297
2. Alter HJ (1988) Transfusion-associated non-A, non-B hepatitis: the first decade. In: Zuckerman AJ (ed) Viral hepatitis and liver disease. Liss, New York, pp 534–
3. Ando K, Moriyama T, Guidotti LG, Wirth S, Schreiber RD, Schlicht HJ, Huang S, Chisari FV (1993) Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J Exp Med 178: 1541–1554
4. Ando K, Guidotti LG, Cerny A, Ishikawa T, Chisari FV (1994a) CTL access to tissue antigen is restricted in vivo. J Immunol 153: 482–488
5. Ando K, Guidotti LG, Wirth S, Ishikawa T, Missale G, Moriyama T, Schreiber RD, Schlicht HJ, Huang S, Chisari FV (1994b) Class I restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J Immunol 152: 3245–3253